The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers
Open accessAbstract
Transforming growth factor-beta (TGF-β) has a dual role in epithelial malignancies, including head and neck squamous cell carcinoma (HNSCC). Attenuation of canonical TGF-β signaling enhances de novo tumor development, whereas TGF-β overexpression and signaling paradoxically promotes malignant progression. We recently observed that TGF-β-induced growth arrest response is attenuated, in association with aberrant activation of nuclear factor-κB (NF-κB), a transcription factor, which promotes malignant progression in HNSCC. However, what role cross-talk between components of the TGF-β and NF-κB pathways plays in altered activation of these pathways has not been established. Here, we show TGF-β receptor II and TGF-β-activated kinase 1 (TAK1) are predominantly expressed in a subset of HNSCC tumors with nuclear activation of NF-κB family member RELA (p65). Further, TGF-β1 treatment induced sequential phosphorylation of TAK1, IKK, IκBα and RELA in human HNSCC lines. TAK1 enhances TGF-β-induced NF-κB activation, as TAK1 siRNA knockdown decreased TGF-β1-induced phosphorylation of IKK, IκB and RELA, degradation of IκBα, RELA nuclear translocation and DNA binding, and NF-κB-induced reporter and target gene transcription. Functionally, TAK1 siRNA inhibited cell proliferation, migration and invasion. Celastrol, a TAK1 inhibitor and anti-inflammatory compound used in traditional Chinese medicine, also decreased TGF-β1-induced phosphorylation of TAK1 and RELA, and suppressed basal, TGF-β1- and tumor necrosis factor-alpha (TNF-α)-induced NF-κB reporter gene activity. Celastrol also inhibited cell proliferation, while increasing sub-G0 DNA fragmentation and Annexin V markers of apoptosis. Furthermore, TGF-β and RELA activation promoted SMAD7 expression. In turn, SMAD7 preferentially suppressed TGF-β-induced SMAD and NF-κB reporters when compared with constitutive or TNF-α-induced NF-κB reporter gene activation. Thus, cross-talk by TGF-β via TAK1 and NF-κB promotes the malignant phenotype of HNSCC. Moreover, NF-κB may contribute to the downstream attenuation of canonical TGF-β signaling through increased SMAD7 expression. Celastrol highlights the therapeutic potential of agents targeting TAK1 as a key node in this pro-oncogenic TGF-β-NF-κB signal pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1
Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., et al. (1996) · Science · doi:10.1126/science.271.5247.350 · Cited by 2,337
Dennler, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3091 · Cited by 1,793
Non-Smad pathways in TGF-β signaling
Zhang, Y. E. (2009) · Cell Research · doi:10.1038/cr.2008.328 · Cited by 1,749
Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer
Siegel, P. M., & Massagué, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1208 · Cited by 1,604
TGFβ signals through a heteromeric protein kinase receptor complex
Wrana, J. L., Attisano, L., Cárcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X.-F., & Massague, J. (1992) · Cell · doi:10.1016/0092-8674(92)90395-s · Cited by 1,526
Identification of a Member of the MAPKKK Family as a Potential Mediator of TGF-β Signal Transduction
Yamaguchi, K., Shirakabe, K., Shibuya, H., Irie, K., Oishi, I., Ueno, N., Taniguchi, T., Nishida, E., & Matsumoto, K. (1995) · Science · doi:10.1126/science.270.5244.2008 · Cited by 1,343
Hayashi, H., Abdollah, S., Qiu, Y., Cai, J., Xu, Y.-Y., Grinnell, B. W., Richardson, M. A., Topper, J. N., Gimbrone, M. A., Wrana, J. L., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80303-7 · Cited by 1,334
Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J.-I., Cao, Z., & Matsumoto, K. (1999) · Nature · doi:10.1038/18465 · Cited by 1,182
Bhowmick, N. A., Ghiassi, M., Bakin, A., Aakre, M., Lundquist, C. A., Engel, M. E., Arteaga, C. L., & Moses, H. L. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.1.27 · Cited by 1,004
The diverse and complex roles of NF-κB subunits in cancer
Perkins, N. D. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3204 · Cited by 852
Cui, W., Fowlis, D. J., Bryson, S., Duffie, E., Ireland, H., Balmain, A., & Akhurst, R. J. (1996) · Cell · doi:10.1016/s0092-8674(00)80127-0 · Cited by 628
Takaesu, G., Kishida, S., Hiyama, A., Yamaguchi, K., Shibuya, H., Irie, K., Ninomiya-Tsuji, J., & Matsumoto, K. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80244-0 · Cited by 610
Yang, H., Chen, D., Cui, Q. C., Yuan, X., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4529 · Cited by 586
TRAF6 Mediates Smad-Independent Activation of JNK and p38 by TGF-β
Yamashita, M., Fatyol, K., Jin, C., Wang, X., Liu, Z., & Zhang, Y. E. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.09.002 · Cited by 559
The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner
Sorrentino, A., Thakur, N., Grimsby, S., Marcusson, A., von Bulow, V., Schuster, N., Zhang, S., Heldin, C.-H., & Landström, M. (2008) · Nature Cell Biology · doi:10.1038/ncb1780 · Cited by 553
Mu, Y., Gudey, S. K., & Landström, M. (2012) · Cell and Tissue Research · doi:10.1007/s00441-011-1201-y · Cited by 545
A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA.
Bitzer, M., von Gersdorff, G., Liang, D., Dominguez-Rosales, A., Beg, A. A., Rojkind, M., & Böttinger, E. P. (2000) · PubMed · Cited by 461
Clay, M. R., Tabor, M., Owen, J. H., Carey, T. E., Bradford, C. R., Wolf, G. T., Wicha, M. S., & Prince, M. E. (2010) · Head & Neck · doi:10.1002/hed.21315 · Cited by 447
A mechanism of suppression of TGF–β/SMAD signaling by NF-κB/RelA
Bitzer, M., von Gersdorff, G., Liang, D., Dominguez-Rosales, A., Beg, A. A., Rojkind, M., & Böttinger, E. P. (2000) · Genes & Development · doi:10.1101/gad.14.2.187 · Cited by 421
(2004) · Planta Medica · doi:10.1055/s-2004-815483 · Cited by 409
Sethi, G., Ahn, K. S., Pandey, M. K., & Aggarwal, B. B. (2007) · Blood · doi:10.1182/blood-2006-10-050807 · Cited by 336
Lam, L. T., Davis, R. E., Pierce, J., Hepperle, M. E., Xu, Y., Foley, M. H., Nong, Y., Wen, D., Adams, J., Dang, L., et al. (2005) · PubMed · Cited by 312
Genotyping of 73 UM‐SCC head and neck squamous cell carcinoma cell lines
Brenner, J. C., Graham, M. P., Kumar, B., Saunders, L. M., Kupfer, R., Lyons, R. H., Bradford, C. R., & Carey, T. E. (2010) · Head & Neck · doi:10.1002/hed.21198 · Cited by 304
Nuclear Factor-κB in Development, Prevention, and Therapy of Cancer
Van Waes, C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2221 · Cited by 292
Self-citationThe IκB kinase complex: master regulator of NF-κB signaling
Solt, L. A., & May, M. J. (2008) · Immunologic Research · doi:10.1007/s12026-008-8025-1 · Cited by 284
Tao, X., Younger, J., Fan, F. Z., Wang, B., & Lipsky, P. E. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10411 · Cited by 282
TGFβ1 Inhibits NF-κB/Rel Activity Inducing Apoptosis of B Cells: Transcriptional Activation of IκBα
Arsura, M., Wu, M., & Sonenshein, G. E. (1996) · Immunity · doi:10.1016/s1074-7613(00)80307-6 · Cited by 250
Signaling Mechanism of TGF-β1 in Prevention of Renal Inflammation: Role of Smad7
Wang, W., Huang, X. R., Li, A. G., Liu, F., Li, J.-H., Truong, L. D., Wang, X. J., & Lan, H. Y. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004121070 · Cited by 236
Sakurai, H., Miyoshi, H., Toriumi, W., & Sugita, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.10641 · Cited by 230
Bancroft, C. C., Chen, Z., Yeh, J., Sunwoo, J. B., Yeh, N. T., Jackson, S., Jackson, C., & Van Waes, C. (2002) · International Journal of Cancer · doi:10.1002/ijc.10398 · Cited by 230
Self-citationEdlund, S., Bu, S., Schuster, N., Aspenström, P., Heuchel, R., Heldin, N.-E., ten Dijke, P., Heldin, C.-H., & Landström, M. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.02-03-0037 · Cited by 226
Wolf, J., Chen, Z., Dong, G., Sunwoo, J. B., Bancroft, C. C., Capo, D. E., Yeh, N. T., Mukaida, N., & Waes, C. V. (2001) · PubMed · Cited by 215
Self-citationBornstein, S., White, R., Malkoski, S., Oka, M., Han, G., Cleaver, T., Reh, D., Andersen, P., Gross, N., Olson, S., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38854 · Cited by 215
Prostate Stem Cell Antigen Is Overexpressed in Prostate Cancer Metastases
Lam, J. S., Yamashiro, J., Shintaku, I. P., Vessella, R. L., Jenkins, R. B., Horvath, S., Said, J. W., & Reiter, R. E. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1842 · Cited by 211
Lu, S.-L., Herrington, H., Reh, D., Weber, S., Bornstein, S., Wang, D., Li, A. G., Tang, C.-F., Siddiqui, Y., Nord, J., et al. (2006) · Genes & Development · doi:10.1101/gad.1413306 · Cited by 204
Jackson-Bernitsas, D. G., Ichikawa, H., Takada, Y., Myers, J. N., Lin, X. L., Darnay, B. G., Chaturvedi, M. M., & Aggarwal, B. B. (2007) · Oncogene · doi:10.1038/sj.onc.1209945 · Cited by 203
Irie, T., Muta, T., & Takeshige, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01146-7 · Cited by 190
Attisano, L., & Lee-Hoeflich, S. T. (2001) · Genome biology · doi:10.1186/gb-2001-2-8-reviews3010 · Cited by 171
Hong, S., Lim, S., Li, A. G., Lee, C., Lee, Y. S., Lee, E., Park, S. H., Wang, X., & Kim, S. (2007) · Nature Immunology · doi:10.1038/ni1451 · Cited by 146
Arsura, M., Panta, G. R., Bilyeu, J. D., Cavin, L. G., Sovak, M. A., Oliver, A. A., Factor, V. M., Heuchel, R. L., Mercurio, F., Thorgeirsson, S. S., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206132 · Cited by 141
Yasui, T., Kadono, Y., Nakamura, M., Oshima, Y., Matsumoto, T., Masuda, H., Hirose, J., Omata, Y., Yasuda, H., Imamura, T., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.357 · Cited by 114
Lee, T., Yeh, J., Friedman, J., Yan, B., Yang, X., Yeh, N. T., Waes, C. V., & Chen, Z. (2008) · International Journal of Cancer · doi:10.1002/ijc.23324 · Cited by 110
Self-citationTGFβ signaling in head and neck squamous cell carcinoma
White, R. A., Malkoski, S. P., & Wang, X. (2010) · Oncogene · doi:10.1038/onc.2010.306 · Cited by 106
Lu, T., Burdelya, L. G., Swiatkowski, S. M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402048101 · Cited by 104
Bian, Y., Terse, A., Du, J., Hall, B., Molinolo, A., Zhang, P., Chen, W., Flanders, K. C., Gutkind, J. S., Wakefield, L. M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4623 · Cited by 99
Self-citationDowdy, S. C., Mariani, A., & Janknecht, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307202200 · Cited by 97
Arsura, M., Fitzgerald, M. J., Fausto, N., & Sonenshein, G. E. (1997) · PubMed · Cited by 90
Sovak, M. A., Arsura, M., Zanieski, G., Kavanagh, K. T., & Sonenshein, G. E. (1999) · PubMed · Cited by 87
Xie, W. Q., Bharathy, S., Kim, D. S., Haffty, B. G., Rimm, D. L., & Reiß, M. (2003) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/000000003108748612 · Cited by 65
Azuma, M., Motegi, K., Aota, K., Yamashita, T., Yoshida, H., & Sato, M. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4503 · Cited by 61
Friedman, J., Nottingham, L. K., Duggal, P., Pernas, F. G., Yan, B., Yang, X. P., Chen, Z., & Waes, C. V. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1591 · Cited by 60
Self-citationYan, B., Yang, X., Lee, T., Friedman, J., Tang, J., Waes, C. V., & Chen, Z. (2007) · Genome biology · doi:10.1186/gb-2007-8-5-r78 · Cited by 56
Self-citationSheng, H., Shao, J., O'Mahony, C. A., Lamps, L. W., Albo, D., Isakson, P. C., Berger, D. H., DuBois, R. N., & Beauchamp, R. D. (1999) · Oncogene · doi:10.1038/sj.onc.1202397 · Cited by 56
Hong, S., Lee, C., & Kim, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1179 · Cited by 52
Chatterjee, A., Chang, X., Sen, T., Ravi, R. K., Bedi, A., & Sidransky, D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2613 · Cited by 43
Cohen, J., Chen, Z., Lu, S., Yang, X. P., Arun, P., Ehsanian, R., Brown, M. S., Lü, H., Yan, B., Diallo, O. T., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3704 · Cited by 37
Self-citationExpression of TAK1, a mediator of TGF-β and BMP signaling, during mouse embryonic development
Jadrich, J. L., O’Connor, M. B., & Coucouvanis, E. C. (2003) · Gene Expression Patterns · doi:10.1016/s1567-133x(03)00012-7 · Cited by 34
Cited by
Signaling Cross Talk between TGF-β/Smad and Other Signaling Pathways
Luo, K. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022137 · Cited by 639
Chen, S.-R., Dai, Y., Zhao, J., Lin, L., Wang, Y., & Wang, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00104 · Cited by 326
Pericyte MyD88 and IRAK4 control inflammatory and fibrotic responses to tissue injury
Leaf, I. A., Nakagawa, S., Johnson, B. G., Cha, J. J., Mittelsteadt, K., Guckian, K. M., Gomez, I. G., Altemeier, W. A., & Duffield, J. S. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87532 · Cited by 151
Cancer-associated fibroblasts enact field cancerization by promoting extratumoral oxidative stress
Chan, J. S. K., Tan, M. J., Sng, M. K., Teo, Z., Phua, T., Choo, C. C., LI, L., Zhu, P., & Tan, N. S. (2017) · Cell Death & Disease · doi:10.1038/cddis.2016.492 · Cited by 130
Inhibition of NF-κB by ACT001 reduces fibroblast activity in idiopathic pulmonary fibrosis
Jaffar, J., Glaspole, I., Symons, K., & Westall, G. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111471 · Cited by 45
Metadata
- Authors
- Freudlsperger, C., Bian, Y., Contag Wise, S., Burnett, J., Coupar, J., Yang, X., Chen, Z., & Van Waes, C.
- Venue
- Oncogene
- Published
- 2012-05-28
- Volume
- 32
- Issue
- 12
- Pages
- 1549-1559
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2076652911
- Cited by
- 290
- References
- 60
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.